Shots:

• Abbott to provide its neuromodulation technologies including deep brain stimulation (DBS)- spinal cord stimulation (SCS)- and dorsal root ganglion (DRG) therapy. NIH to utilize Abbott’s technology for exploring its applications in chronic pain and progressive movement disorders as Parkinson’s disease
• The focus of the collaboration is to accelerate the application of Abbott’s neurostimulation therapies- exploring new avenues for neurological conditions
• Abbott’s neuromodulation technologies determine the inner workings of the nervous system- allowing to explore the interaction of the brain with the human body in patients with neurological conditions

Ref: Abbott | Image:  Abbott